Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation

被引:186
作者
Qin, BY
Liu, C
Lam, SS
Srinath, H
Delston, R
Correia, JJ
Derynck, R [1 ]
Lin, K
机构
[1] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA
[2] Univ Calif San Francisco, Dept Growth & Dev, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Anat, Cell Biol Program, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA
[5] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nsb1002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IRF-3, a member of the interferon regulatory factor (IRF) family of transcription factors, functions as a molecular switch for antiviral activity. IRF-3 uses an autoinhibitory mechanism to suppress its transactivation potential in uninfected cells, and virus infection induces phosphorylation and activation of IRF-3 to initiate the antiviral responses. The crystal structure of the IRF-3 transactivation domain reveals a unique autoinhibitory mechanism, whereby the IRF association domain and the flanking autoinhibitory elements condense to form a hydrophobic core. The structure suggests that phosphorylation reorganizes the autoinhibitory elements, leading to unmasking of a hydrophobic active site and realignment of the DNA binding domain for transcriptional activation. IRF-3 exhibits marked structural and surface electrostatic potential similarity to the MH2 domain of the Smad protein family and the FHA domain, suggesting a common molecular mechanism of action among this superfamily of signaling mediators.
引用
收藏
页码:913 / 921
页数:9
相关论文
共 49 条
[1]   Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes [J].
Au, WC ;
Moore, PA ;
LaFleur, DW ;
Tombal, B ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :29210-29217
[2]   Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3 [J].
Au, WC ;
Yeow, WS ;
Pitha, PM .
VIROLOGY, 2001, 280 (02) :273-282
[3]   On the role of IRF in host defense [J].
Barnes, B ;
Lubyova, B ;
Pitha, PM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (01) :59-71
[4]   Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes [J].
Barnes, BJ ;
Kellum, MJ ;
Field, AE ;
Pitha, PM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (16) :5721-5740
[5]   Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[6]   Pip, a lymphoid-restricted IRF, contains regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1 [J].
Brass, AL ;
Kehrli, E ;
Eisenbeis, CF ;
Storb, U ;
Singh, H .
GENES & DEVELOPMENT, 1996, 10 (18) :2335-2347
[7]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[8]   The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization [J].
Chacko, BM ;
Qin, B ;
Correia, JJ ;
Lam, SS ;
de Caestecker, MP ;
Lin, K .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (03) :248-253
[9]   The molecular basis of FHA Domain:Phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms [J].
Durocher, D ;
Taylor, IA ;
Sarbassova, D ;
Haire, LF ;
Westcott, SL ;
Jackson, SP ;
Smerdon, SJ ;
Yaffe, MB .
MOLECULAR CELL, 2000, 6 (05) :1169-1182
[10]   Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens [J].
Eroshkin, A ;
Mushegian, A .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05) :403-405